Condition
Postpartum Smoking Relapse
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04098874Phase 4RecruitingPrimary
Bupropion for the Prevention of Postpartum Smoking Relapse
NCT04114877Not ApplicableCompletedPrimary
Perinatal Attentional Retraining Intervention for Smoking for Minority Women
NCT05711225Not ApplicableCompletedPrimary
Transtheoretic Model, Postpartum Smoking Relapse, Smoking Cessation Intervention
Showing all 3 trials